Herbal kava: reports of liver toxicity

E Wooltorton - CMAJ, 2002 - Can Med Assoc
Reason for posting: Health Canada advises that products containing kava should not be
used. 1 The drug is used in a variety of herbal and homeopathic preparations to induce …

[PDF][PDF] Kava update: a European perspective

E Ernst - NZ Med J, 2004 - Citeseer
Kava is the beverage prepared from the rhizome of the kava plant (Piper methysticum
Forster), and is traditionally used for recreational or medicinal purposes by the islanders of …

Kava extracts: safety and risks including rare hepatotoxicity

R Teschke, W Gaus, D Loew - Phytomedicine, 2003 - Elsevier
Kava is a perennial shrub native to some islands of the South Pacific and has been
cultivated for centuries to prepare a psychoactive beverage from its rhizoma by means of …

Kava: a risk-benefit assessment

M Schmidt, M Morgan, K Bone… - The essential guide to …, 2005 - books.google.com
In November 2001 the German Health Authority (BfArM; see Appendix 1 for abbreviations
used) announced that it was intending to ban the use of kava (Piper methysticum) because …

Kava kava: examining new reports of toxicity

DL Clouatre - Toxicology Letters, 2004 - Elsevier
Before 1998, extracts of kava kava, Piper methysticum, were considered to be very safe
alternatives to anxiolytic drugs and to possibly exert a wide range of other benefits. Major …

Risk of kava hepatotoxicity and the FDA consumer advisory

R Teschke, J Schulze - Jama, 2010 - jamanetwork.com
IN EARLY 2002, THE US FOOD AND DRUG ADMINISTRA-tion (FDA) began advising
consumers of the poten-tial risk of severe liver injury associated with the use of kava …

[PDF][PDF] Kava hepatotoxicity: a European view

R Teschke, A Schwarzenboeck, A Akinci - The New Zealand Medical …, 2008 - Citeseer
Kava was well tolerated and considered as devoid of major side effects only until 1998 when
the first report of assumed kava hepatotoxicity appeared. Causality of hepatotoxicity for …

[CITATION][C] Another FDA warning: Kava supplements

CA Parkman - The Case Manager, 2002 - Elsevier
TABLE 1. FDA CONSUMER WARNING REGARDING KAVA AND LIVER SYMPTOMS not
classify the herb as a drug and considers it a dietary supplement. That fact is key in helping …

[HTML][HTML] The safety of kava–a regulatory perspective

WN Richardson, L Henderson - British journal of clinical …, 2007 - ncbi.nlm.nih.gov
Kava (Piper methysticum) was prohibited in unlicensed medicines in the United Kingdom 4
years ago, following an extensive evaluation of the potential for kava products to produce …

Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited

R Teschke, J Sarris, I Schweitzer - British journal of clinical …, 2012 - Wiley Online Library
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• The rhizome of the Pacific kava plant
(Piper methysticum) contains as its active constituents numerous kavalactones known for …